Christopher G. Chavez
Chairman, CEO, and President
Christopher G. Chavez joined us as President, Chief Executive Officer and Chairman in April 2012. Mr. Chavez has over 30 years of leadership experience in the medical device industry. From 2005 through August 2011, Mr. Chavez served as President of the Neuromodulation Division of St. Jude Medical, Inc., or St. Jude Medical, and served as CEO, President and Director of Advanced Neuromodulation Systems, or ANS, from 1998 until its acquisition by St. Jude Medical in 2005. Prior to ANS, Mr. Chavez spent 17 years at Johnson & Johnson, most recently as Vice President and General Manager of the Infection Control Business Unit. Mr. Chavez served on the board of directors of Advanced Medical Optics Inc. from 2002 until it was acquired by Abbott Laboratories Inc. in 2009. Mr. Chavez has previously served as Chairman of the Medical Device Manufacturers Association and Chairman of the Dallas/Fort Worth Health Industry Council. Mr. Chavez received his M.B.A. from Harvard Business School and his Bachelors of Accountancy from New Mexico State University, Las Cruces.
Michael R. Kramer
Chief Financial Officer
Michael R. Kramer joined us as Chief Financial Officer in September 2010. Prior to joining us, Mr. Kramer served as Chief Financial Officer at ATS Medical, Inc., or ATS, a publicly traded cardiovascular device company, from July 2007 to September 2010. From October 2006 to July 2007 Mr. Kramer served as Senior Director of Finance and acting Chief Financial Officer of ATS. Prior to ATS, Mr. Kramer served as Controller at CABG Medical, Inc., a cardiovascular device manufacturer and as Corporate Finance Manager at Ecolab, Inc., a developer and marketer of products and services to the hospital, foodservice, healthcare and industrial markets. Prior to Ecolab, Inc., Mr. Kramer was a manager in the assurance and advisory services practice at the professional services firm of Ernst & Young LLP. Mr. Kramer received his Bachelors of Accountancy from the University of North Dakota. Mr. Kramer is a certified public accountant (inactive).
Michael V. Chobotov, Ph.D.
Chief Technology Officer; Co-founder
Michael V. Chobotov, Ph.D. co-founded TriVascular as President and CEO in 1998, and led its spin-off from Boston Scientific Corporation in 2008, serving as President and CEO until 2012. He currently serves as our Chief Technology Officer and as a member of the our board of directors. Prior to co-founding TriVascular in 1998, Dr. Chobotov co-founded TransMotive Technologies, an engineering and product development consulting company. Previously, Dr. Chobotov served as Senior Vice President of R&D and board member of U.S. Electricar, and Senior Systems Engineer at Hughes Space and Communications. He also led the design of the Lunar Prospector, which was subsequently implemented as the first NASA Discovery mission. Dr. Chobotov received his Ph.D. in Mechanical Engineering, his M.S. in Mechanical Engineering and his B.S. in Engineering and Applied Science, all from the California Institute of Technology.
Robert G. Whirley, Ph.D.
Vice President, Research and Development; Co-founder
Robert G. Whirley, Ph.D. co-founded TriVascular in 1998, and currently serves as our Vice President, Research and Development. Prior to rejoining TriVascular in March 2008, Dr. Whirley worked as an independent consultant starting in August 2006. Prior to his work as a consultant, Dr. Whirley served as Vice President, Research and Development for Vascular Surgery for Boston Scientific Corporation after it acquired TriVascular in May 2005. Prior to co-founding TriVascular in 1998, Dr. Whirley’s previous experience included co-founder and Vice President, Engineering for TransMotive Technologies, Vice President of Technology R&D for U.S. Electricar, and President of Livermore Research and Engineering Corp. Dr. Whirley received his Ph.D. in Mechanical Engineering from the California Institute of Technology, his M.S. in Applied Mechanics from the California Institute of Technology, and his Bachelors of Mechanical Engineering from Georgia Institute of Technology.
Kimberley A. Elting
General Counsel and Vice President, Corporate Affairs
Kimberley A. Elting joined us as General Counsel and Vice President, Corporate Affairs in March 2013. In July 2013 she was appointed our Chief Compliance Officer. In this role, Ms. Elting leads the legal, compliance, human resources and government affairs functions, and also serves as the company’s corporate Secretary. Prior to joining us, Ms. Elting served in various roles of increasing responsibility with St. Jude Medical, most recently as General Counsel and Vice President Human Resources & Health Policy for the Neuromodulation division of St. Jude Medical, from January 2007 to January 2013. Prior to joining St. Jude Medical, Ms. Elting was a partner at the Jones Day law firm where she counseled clients in the health care sector on mergers & acquisitions and regulatory matters. Ms. Elting received her B.A. in Politics from Ithaca College, her J.D. from the University of Denver and her LL.M. in Health Law from Loyola University Chicago.
Vivek K. Jayaraman
Vice President, Global Sales and Marketing
Vivek K. Jayaraman joined us as Vice President, Global Sales and Marketing in October 2009. Mr. Jayaraman previously served in various roles of increasing responsibility at Medtronic, Inc. from 2001 to 2009, most recently as the Vice President of Global Marketing—Endovascular Innovations. Previously, Mr. Jayaraman led Medtronic’s Peripheral Vascular business, worked as a Policy Fellow in Medtronic’s Government Affairs Office in Washington, D.C. and served as an expatriate in Hong Kong and Tokyo in a sales leadership role. Mr. Jayaraman also worked at the Johnson & Johnson Development Corporation, and began his career at The Wilkerson Group, a healthcare focused management consultancy. Mr. Jayaraman received his M.B.A. in Health Care Management from The Wharton School at The University of Pennsylvania and his dual B.S. degree in Biology and History from the University of Michigan.
Louis J. Molinari
Vice President, Manufacturing Operations
Louis J. Molinari rejoined us as Vice President, Manufacturing Operations in April 2008. Prior to that, Mr. Molinari served as Director of Operations for Brooks Automation, Inc. from May 2007 to April 2008. Mr. Molinari also previously served as Director of Manufacturing/Process Development Engineering for TriVascular and in the same role for Boston Scientific Corporation. Mr. Molinari received his B.S. in Electrical Engineering from California Polytechnic University, San Luis Obispo.
Shari L. O'Quinn
Vice President, Clinical/Regulatory Affairs and Quality Assurance
Shari L. O’Quinn joined us as Vice President, Clinical/Regulatory Affairs and Quality in September 2009. Ms. O’Quinn previously served as the Vice President of Clinical and Regulatory at Aptus Endosystems, Inc. from February 2007 to August 2009. Prior to that, Ms. O’Quinn served as Director of Clinical and Regulatory at Bard Peripheral Vascular. Ms. O’Quinn began her career as a consultant at Quintiles Medical Technology Consultants where she specialized in developing global clinical and regulatory strategies for commercialization of implantable cardiovascular devices. Ms. O’Quinn received her B.A. from the University of Virginia.
Joseph W. Humphrey, Ph.D.
Vice President, Manufacturing Technology; Co-founder
Joseph W. Humphrey, Ph.D. co-founded TriVascular in 1998, and serves as our Vice President of Manufacturing Technology. Dr. Humphrey has held numerous positions with our company, including Vice President of Administration, CFO, and CIO. Prior to TriVascular, Dr. Humphrey co-founded TransMotive Technologies, where he served as Vice President of Technology. Prior to that, Dr. Humphrey served as Vice President of Programs for U.S. Electricar, Co-founder and President of Advanced Projects Research Inc., Research Scientist at the Marquardt Company, and Research Scientist at the Aerojet Propulsion Research Institute. Dr. Humphrey received his B.S. degree in Mechanical Engineering from the Georgia Institute of Technology, his M.S. in Mechanical Engineering from California Institute of Technology, and his Ph.D. in Mechanical Engineering from the California Institute of Technology.
Shane T. Gleason
Vice President of Sales - U.S.
Shane T. Gleason joined us as Vice President, U.S. Sales in August 2010. Mr. Gleason joined us from Abbott Laboratories, or Abbott, where he served in a variety of Sales and Marketing roles of increasing leadership responsibility within the vascular business from 2002 to 2010, most recently as the Director of Global Marketing for Abbott Vascular’s Endovascular franchise. Prior to Abbott, Mr. Gleason held sales positions with Smiths Medical Level 1 and Medline Industries. Mr. Gleason received his B.S. in Engineering Science and Mechanics with a concentration in Biomechanical Engineering from the Virginia Polytechnic Institute and State University and his M.B.A. from The Robert H. Smith School of Business at the University of Maryland.
Robert T. Woolley
Vice President of Sales - Europe
Robert T. Woolley joined us as the International Director of Commercial Operations, based in Switzerland, in March 2010. Previously, Mr. Woolley worked for the Dow Chemical Company from 2008 to August 2010 and from 1999 to 2003. Mr. Woolley also previously worked for Medtronic from 2005 to 2008 in various capacities, including cardiac rhythm management, spine and biologics, diabetes, and diagnostics in both the United States and Europe. Mr. Woolley received his B.S. in Mechanical Engineering from Brigham Young University and his M.B.A. from Harvard Business School.